Komori
Medipal Holdings (7459) · InitiativeAdvanced

Reducing Carbon Dioxide Emissions by Reviewing Delivery Frequency

First written in FY2021. 8 of 8 entries say "Advanced", first in FY2021. Latest entry: 2026-09-01.

8entries
6years
2from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseAdvancedFY2021 – 2026-09-012021: 220212022: 220222023: 020232024: 020242025: 120252026: 32026
Same theme, other companies
Reducing Delivery and Packaging Materials and Improving Logistics EfficiencyA theme 15 companies write about · 0 as a headwind · 15 as a tailwind

6 other companies' latest entry also says "Advanced".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 15 companies compared. The sentences above are computed from all 15.
Full recordFilings, disclosures and news, newest first
  1. 2026-09-01AdvancedOther Disclosures

    「As certain results were confirmed, including improved logistics efficiency and high evaluations from the stores receiving deliveries, we decided to launch joint delivery operations in the Kansai area based on those results.」

    The joint delivery operations between PALTAC CORPORATION and ARATA CORPORATION, which began in the West Kanto area, expanded to the Kansai area based on certain results. The disclosure cited improved logistics efficiency, optimized logistics costs, reduced CO2 emissions and fewer receiving operations at stores, and stated that further expansion of the joint delivery areas was planned.
  2. FY2026AdvancedAnnual report

    「In July 2025, 株式会社PALTAC agreed to promote cooperation with 株式会社あらた in non-competitive areas, with the aim of co-creating sustainable distribution infrastructure. As the first stage, the companies began joint deliveries in the western Kanto area.」

    Regarding sustainable logistics and supply-chain optimization, PALTAC and あらた began joint deliveries in the western Kanto area.
  3. 2026-05-14AdvancedEarnings

    「In July 2025, PALTAC CORPORATION (Chuo-ku, Osaka; hereinafter, “PALTAC”) agreed with ARATA CORPORATION (Koto-ku, Tokyo) to promote collaboration in “non-competitive areas” with the aim of co-creating a sustainable distribution infrastructure, and began joint delivery operations in the West Kanto area as the first phase.」

    The disclosure described the launch of joint deliveries with ARATA CORPORATION in the West Kanto area as a specific initiative to create sustainable distribution infrastructure at PALTAC.
  4. FY2025AdvancedAnnual report

    「In January 2025, 株式会社PALTAC entered into a basic agreement with 三菱食品株式会社 (Bunkyo-ku, Tokyo) to collaborate and cooperate in building sustainable logistics and further expanding both companies’ logistics businesses, with the aim of achieving efficient and sustainable logistics through cross-industry collaboration. The companies are promoting initiatives to expand the scope of value delivered through logistics.」

    Regarding sustainable logistics and supply-chain optimization, PALTAC entered into a basic agreement with 三菱食品 in January 2025.
  5. FY2022AdvancedAnnual report

    「In June 2021, 株式会社メディセオ, a wholly owned consolidated subsidiary of the Company (Chuo-ku, Tokyo), began initiatives with 株式会社ツルハ, which operates pharmacies and drugstores (Higashi-ku, Sapporo), to build a new model for optimizing pharmaceutical distribution in order to realize a sustainable society. In October of the same year, it began similar initiatives with 株式会社マツキヨココカラ&カンパニー (Bunkyo-ku, Tokyo).」

    In addition to ツルハ, the Company began initiatives with 株式会社マツキヨココカラ&カンパニー to build a pharmaceutical distribution optimization model encompassing CO2 emissions reductions, productivity improvements and work-style reform.
  6. FY2022-Q3AdvancedAnnual report

    「As part of this initiative, in October 2021, 株式会社メディセオ, a wholly owned consolidated subsidiary of the Company (Chuo-ku, Tokyo; hereinafter, “メディセオ”), and 株式会社マツキヨココカラ&カンパニー (Bunkyo-ku, Tokyo) began initiatives to build a new model for optimizing pharmaceutical distribution in order to realize a sustainable society. Through this initiative, the companies will optimize order-taking, delivery and receipt processes, establish an efficient operating structure for both parties, reduce CO2 emissions, improve productivity and promote work-style reform.」

    In addition to the existing model with ツルハ, メディセオ and 株式会社マツキヨココカラ&カンパニー began a new model for optimizing pharmaceutical distribution and reducing CO2 emissions, covering order-taking, delivery and receipt processes.
  7. FY2022-Q1AdvancedAnnual report

    「In June of the same year, 株式会社メディセオ, a wholly owned consolidated subsidiary of the Company, and 株式会社ツルハ, which operates pharmacies and drugstores, began initiatives to build a new pharmaceutical distribution model for realizing a sustainable society. Through this initiative, the companies will establish an efficient operating structure for both parties while reducing CO2 emissions, improving productivity and promoting work-style reform.」

    メディセオ and ツルハ began building a new pharmaceutical distribution model to improve logistics efficiency, including reducing CO2 emissions, and expanded the initiative to include productivity improvements and work-style reform.
  8. FY2021AdvancedAnnual report

    「In addition, to optimize and improve efficiency across the entire supply chain, from pharmaceutical companies to patients, we are undertaking various initiatives to maximize the capabilities of our wholesale functions.」

    From an SDG perspective, we position the reduction of carbon dioxide emissions through measures such as reviewing delivery frequency as an initiative to optimize the supply chain.
Moved together

"Building PALTAC’s sales-driving model using in-store information" moved the same way as this thread, in the same document, in 7 of its 8 moves.

754444★123456
  1. ★This thread
  2. 1Building PALTAC’s sales-driving model using in-store information7×
  3. 2Revenue Diversification through Strengthening Logistics and Sales Functions and Creating New Businesses5×
  4. 3Nationwide expansion of prescription pharmaceutical logistics functions through ALC and FLC logistics centers4×
  5. 4Risk Management Framework Based on Rules, Training, Manuals and Internal Audit4×
  6. 5Drug Discovery and U.S. Expansion Through a Business and Capital Alliance with JCR Pharmaceuticals4×
  7. 6Suspected Antimonopoly Act Violations Over JCHO Tenders and Japan Fair Trade Commission Inspection4×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
Medipal Holdings's next results are scheduled for 2026-11-05. Read the earnings preview It last moved in the Other Disclosures of 2026-09-01: "Advanced".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Reducing Carbon Dioxide Emissions by Reviewing Delivery Frequency | MEDIPAL HOLDINGS CORPORATION (7459) | Komori